Literature DB >> 11515899

Peroxynitrite formation from human myocardium after ischemia-reperfusion during open heart operation.

Y Hayashi1, Y Sawa, S Ohtake, N Fukuyama, H Nakazawa, H Matsuda.   

Abstract

BACKGROUND: Current experimental studies have demonstrated that peroxynitrite (ONOO-) has both cytotoxic and cytoprotective effects on myocardial ischemia-reperfusion injury. However, even myocardial ONOO- formation has not yet been investigated in humans undergoing open heart operation. We measured plasma nitrotyrosine as an indicator of ONOO- formation during open heart operation and examined its association with myocardial ischemia-reperfusion injury.
METHODS: Twenty adult patients undergoing mitral valve replacement under cardiopulmonary bypass between 1997 and 1998 were enrolled in this study (6 men and 14 women). Arterial blood (Ao) and coronary sinus effluent (CS) were obtained: (1) before the initiation of cardiopulmonary bypass, (2) just after aortic unclamping, (3) at 5 minutes, (4) at 10 minutes, (5) at 15 minutes, and (6) at 20 minutes after aortic unclamping.
RESULTS: At every sampling point after reperfusion, plasma nitrate and nitrite was significantly lower in CS than in Ao, and the percentage ratio of nitrotyrosine to tyrosine (%NO2-Tyr; an index of ONOO- formation) was significantly higher in CS than in Ao. The CS-Ao difference in %NO2-Tyr, myocardium-derived ONOO-, reached its peak at 5 minutes after reperfusion (2.17+/-0.74%), which was significantly correlated with the peak CS-Ao difference in plasma malondialdehyde, and with postoperative maximum creatine kinase-MB.
CONCLUSIONS: These results first demonstrate that ONOO- is produced from human myocardium after ischemia-reperfusion during open heart operation, and myocardium-derived ONOO- can be determined by the CS-Ao difference in %NO2-Tyr.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11515899     DOI: 10.1016/s0003-4975(01)02668-6

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  11 in total

Review 1.  Modulation of the conformational state of mitochondrial complex I as a target for therapeutic intervention.

Authors:  Alexander Galkin; Salvador Moncada
Journal:  Interface Focus       Date:  2017-04-06       Impact factor: 3.906

2.  Tyrosine nitration of mitochondrial proteins during myocardial ischemia and reperfusion.

Authors:  Zuzana Tatarkova; Maria Kovalska; Monika Kmetova Sivonova; Peter Racay; Jan Lehotsky; Peter Kaplan
Journal:  J Physiol Biochem       Date:  2019-05-21       Impact factor: 4.158

3.  Tyrosine nitration of voltage-dependent anion channels in cardiac ischemia-reperfusion: reduction by peroxynitrite scavenging.

Authors:  Meiying Yang; Amadou K S Camara; Bassam T Wakim; Yifan Zhou; Ashish K Gadicherla; Wai-Meng Kwok; David F Stowe
Journal:  Biochim Biophys Acta       Date:  2012-06-15

4.  In vitro study of the antioxidative properties of the glucose derivatives against oxidation of plasma components.

Authors:  Joanna Kolodziejczyk; Joanna Saluk-Juszczak; Barbara Wachowicz
Journal:  J Physiol Biochem       Date:  2010-11-19       Impact factor: 4.158

5.  Clovamide-rich extract from Trifolium pallidum reduces oxidative stress-induced damage to blood platelets and plasma.

Authors:  Joanna Kolodziejczyk; Beata Olas; Barbara Wachowicz; Barbara Szajwaj; Anna Stochmal; Wieslaw Oleszek
Journal:  J Physiol Biochem       Date:  2011-04-05       Impact factor: 4.158

Review 6.  Nitric oxide and peroxynitrite in health and disease.

Authors:  Pál Pacher; Joseph S Beckman; Lucas Liaudet
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

Review 7.  Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease.

Authors:  Pal Pacher; Csaba Szabo
Journal:  Am J Pathol       Date:  2008-06-05       Impact factor: 4.307

Review 8.  Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors.

Authors:  Pál Pacher; Csaba Szabó
Journal:  Cardiovasc Drug Rev       Date:  2007

9.  Hypoxic conditioning suppresses nitric oxide production upon myocardial reperfusion.

Authors:  Myoung-Gwi Ryou; Jie Sun; Kevin N Oguayo; Eugenia B Manukhina; H Fred Downey; Robert T Mallet
Journal:  Exp Biol Med (Maywood)       Date:  2008-04-11

Review 10.  Pyruvate enhancement of cardiac performance: Cellular mechanisms and clinical application.

Authors:  Robert T Mallet; Albert H Olivencia-Yurvati; Rolf Bünger
Journal:  Exp Biol Med (Maywood)       Date:  2017-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.